Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3
Author(s): Glenn Yiu, MD, PhD Fact checked by: Sheryl Stevenson Frequent intravitreal injections for neovascular age-related macular degeneration present a long-term treatment burden, highlighting the need for innovative, durable solutions…